Eighteen laboratories participated in a collaborative study on the determination of clopidol residues in chicken muscle tissues by liquid chromatography. Of these, results from 16 laboratories which rigorously followed the method were subjected to statistical analysis. The method performance was assessed by all participants using 14 samples of chicken muscle fortified at concentrations ranging from 0.1 to 5.0 mg/kg. In addition, 9 participants each reported results for 6 clopidol-incurred samples in chicken muscle. Test portions were extracted with acetonitrile, and the extracts were purified with alumina and anion exchange resin solid-phase extraction cartridges in sequence. Clopidol was separated by reversed-phase liquid chromatography and quantified at 270 nm. Average recoveries ranged from 81.8 to 85.4%, reproducibility relative standard deviation (RSD R ) ranged from 11.9 to 22.6%, and repeatability relative standard deviation (RSD r ) ranged from 9.9 to 15.1%. For clopidol-incurred samples at concentrations of 0.100-0.687 mg/kg, the mean determination value range was 0.099-0.659 mg/kg; RSD R was 12.6-19.8%, RSD r was 3.1-8.5%; and HORRAT values were 0.7-1.1. The accuracy and precision of the method are in conformity with the requirements specified by AOAC INTERNATIONAL. The method was adopted Official First Action in April 2003. C lopidol (3,5-dichloro-2,6-dimethy1-4-pyridinol) is a veterinary medicine used to prevent coccidiosis. It has a very high curative effect and is widely used in the chicken-raising industry. For the purpose of protecting human health, countries and international organizations have laid out stringent regulations on its residue limit in chicken tissues. Earlier analytical methods for clopidol residues in chicken tissues have been based on gas chromatography (GC; 1, 2). AOAC Official Method 974.45 for clopidol residues in animal tissues, adopted Official First Action in 1974 and Final Action in 1977, is based on GC with electron capture detection and is applicable to $0.1 mg/kg clopidol in chicken tissues and $0.05 mg/kg clopidol in eggs (3). Typically, GC-based methods for clopidol, including Official Method 974.45, require the use of either diazomethane or propionic anhydride as a derivatization reagent to reduce the boiling point of clopidol, making it easier to vaporize. However, the problems associated with such derivatizations, including safety concerns with the use of diazomethane, can be avoided if a liquid chromatographic (LC) method is adopted for clopidol determination. Based on an LC method for clopidol residues in chicken tissues by Mtema et al. (4), an extensive study of the extraction, purification, and separation technique was conducted to improve and optimize the analytical conditions and compare method performance with the former GC method (5-7). The results demonstrated that the LC method is simpler to apply than the GC method, although the GC method has a lower detection limit than does the LC method. However, the overall performance and the stability of the LC method is much better than that observed for the GC method.
C lopidol (3,5-dichloro-2,6-dimethy1-4-pyridinol) is a veterinary medicine used to prevent coccidiosis. It has a very high curative effect and is widely used in the chicken-raising industry. For the purpose of protecting human health, countries and international organizations have laid out stringent regulations on its residue limit in chicken tissues. Earlier analytical methods for clopidol residues in chicken tissues have been based on gas chromatography (GC; 1, 2). AOAC Official Method 974.45 for clopidol residues in animal tissues, adopted Official First Action in 1974 and Final Action in 1977, is based on GC with electron capture detection and is applicable to $0.1 mg/kg clopidol in chicken tissues and $0.05 mg/kg clopidol in eggs (3) . Typically, GC-based methods for clopidol, including Official Method 974.45, require the use of either diazomethane or propionic anhydride as a derivatization reagent to reduce the boiling point of clopidol, making it easier to vaporize. However, the problems associated with such derivatizations, including safety concerns with the use of diazomethane, can be avoided if a liquid chromatographic (LC) method is adopted for clopidol determination. Based on an LC method for clopidol residues in chicken tissues by Mtema et al. (4) , an extensive study of the extraction, purification, and separation technique was conducted to improve and optimize the analytical conditions and compare method performance with the former GC method (5) (6) (7) . The results demonstrated that the LC method is simpler to apply than the GC method, although the GC method has a lower detection limit than does the LC method. However, the overall performance and the stability of the LC method is much better than that observed for the GC method.
Over the past 10 years, the LC method has been applied in the analysis of over 10 000 lots of exported chicken, with results that have been accepted for export certificates. Based on this experience, which involved daily routine analysis of incurred samples commonly exceeding the limit of detection (LOD; 0.010 mg/kg), the LC method was considered superior to GC methods in terms of accuracy and precision (8) . There-fore, it was considered appropriate that a study be conducted to establish the LC method as an Official Method of AOAC INTERNATIONAL for clopidol residues in poultry tissue, thus providing international recognition and acceptance of the method for regulatory use.
Collaborative Study
The study protocol was designed in accordance with the AOAC ® Official Methods Program Policies and Procedures Manual (9) .
The 18 participating laboratories included representatives from regulatory organizations, universities or colleges, scientific research institutes, and other governmental laboratories located in Asia, Europe, North America, and South America, all of which were recruited to participate on a voluntary basis. As a result of the widespread foot-and-mouth disease outbreak which affected numerous countries in 2001 and the attendant difficulties in the shipping of chicken samples across international boundaries, the original plan to ship tissue samples from the organizing laboratory was modified so that collaborators purchased chicken muscle in local markets and prepared them into homogeneous, representative blank samples to be used in the study. These samples had to first be shown to be blank (free of detectable clopidol residues), after which the standard fortification solutions supplied by the organizer were added to make the collaborative study samples. Clopidol-incurred samples were also provided as optional samples to 9 domestic laboratories. None of the European and North and South American laboratories were able to receive these samples because of restrictions on the importing of animal tissues.
Fourteen ampules of coded (unknown to participant) fortification solutions were sent to each laboratory to be used in the fortification of 14 collaborative study materials. This comprised 7 randomized pairs of spiking solutions to produce 7 pairs of unknown samples in a randomized design. The design included 2 blanks (spiking solution contained only methanol), plus 6 pairs of spiking solutions ranging from 1 to 50 mg/L clopidol in methanol, corresponding to concentrations of 0.1-5.0 mg/kg when added to the tissue test portions. In addition, 3 ampules of known concentration of standard solutions were shipped to each laboratory to be used to generate a standard calibration curve for quantification of study materials and as practice samples before the testing of study materials. Collaborators were advised to undertake the necessary practice in order to familiarize themselves with the method before analyzing the 14 study materials. Each of the 14 test portions, provided as unknowns to the analyst, was only permitted to be analyzed once. Each collaborator was required to put the fortification solution in each ampule completely into one test portion for a single analysis. All collaborators were required to analyze the samples in strict observance with the specified method, especially paying attention to the conditions for quality assurance. After the fortification solutions and standards were received, collaborators returned a form acknowledging receipt of the study materials in good condition. Collaborators also undertook to complete and report the results to the Study Director, with the original chromatograms, within 3 months.
Sources of Incurred Samples
Arrangements were made with the Qinhuangdao Zhengda Chicken Co. Ltd. for production of broiler chickens with incurred residues at one of its farms. In total, 100 broiler chickens were reared using the conventional production practice (10) and the feeding flow chart as follows: stage 1, from 0 to 21 days, nonmedicated starter feed; stage 2, from 22 to 42 days, feed containing 125 mg/kg clopidol; stage 3, from 43 to 52 days, nonmedicated finishing feed.
Chickens were killed at the beginning of stage 3, after a withdrawal period of 8 h from medicated feed. Samples were taken at random and consisted of 100 g muscle tissue each from the upper breast, lower breast, and leg of each chicken. Each muscle sample was individually sealed in a plastic bag and the 3 muscle samples from each chicken were then packed in a clean plastic bag. Upon delivery to the Study Director's laboratory, the individual samples from each muscle group were pooled and then blended to produce homogeneous incurred samples which were sent to the collaborators for determination of clopidol residue concentration.
Treatment of Data
Participants tabulated and reported their results to the Study Director. These results were reviewed against the analytical records provided by each participant to ensure that there were no transcription errors before statistical analysis, which was conducted according to standard procedures as required by AOAC INTERNATIONAL (11, 12) . Each collaborator was also required to state any deviations from the written protocol that had occurred in their laboratory. The significance of any deviations was reviewed by the Study Director to determine if such deviations were grounds for rejection of the results from that participant. 
A. Principle
Clopidol is extracted from chicken muscle with acetonitrile. The extracts are cleaned up on an alumina column and then on an anion exchange column. Clopidol is separated from co-extractives by reversed-phase LC and quantitated at 270 nm. 
B. Reagents

C. Apparatus
(a) Liquid chromatograph.-LC system consisting of solvent delivery pump, universal LC injector with 10 mL syringe, UV detector capable of monitoring 270 nm, and data output device (recorder, integrator, or data system is recommended for measuring peak heights). If LC is not equipped with de-gas module, gently sparge mobile phase with helium for 5 min immediately before use. Set flow rate of mobile phase at 1.0 mL/min; set detector wavelength at 270 nm with sensitivity of 0.01 absorbance unit full scale. Peak resolution should be as indicated in of glass wool at bottom of column; fill with 40 mL methanol, pour in 15 g alumina, and tap on sides of column to produce even settling of bed; drain solvent. Prerinse column with 10 mL methanol to condition; drain solvent to top of packing material.
(h) Anion exchange column.-Chromatographic tubes (250´10 mm id) with sintered glass disk, fitted with draw-off valve. Place small plug of glass wool at bottom of column, and then fill column with 20 mL methanol. Add sufficient anion exchange resin to column to form bed height of 2-3 cm after settling by tapping gently on sides of column. Drain methanol; then prerinse column with 10 mL methanol to condition, draining solvent to top of column bed. 
E. Preparation of Test Extracts
Accurately weigh 10.0 g representative minced chicken muscle into 80 mL glass centrifuge tube. Add 20 g anhydrous sodium sulfate and 35 mL acetonitrile, and homogenize for 1.5 min at 15 000 rpm. Centrifuge for 3 min at 1400´g. Use holder to position preconditioned alumina column, C(g), above preconditioned anion exchange column, C(h), as shown in Figure 2003 .04B, while ensuring that methanol levels in columns do not drop below level of respective packing materials. Decant clear tissue extract into alumina column and let it run through both columns to waste at approximately 3 mL/min, making sure that tissue extract levels in columns do not drop below level of respective packing materials. Re-extract by adding 35 mL acetonitrile to tissue sediment plug, and mix on a Vortex mixer to break up tissue sediment. Disrupt plug with a spatula, if required. Recentrifuge and apply tissue extracts to assembled columns. Rinse assembled columns with 20 mL methanol. Remove alumina column and rinse separately with additional 20 mL methanol. Elute clopidol off anion exchange column with 20 mL 0.5% acetic acid-methanol mixture into 100 mL evaporating flask. Evaporate to dryness on rotary evaporator at 60°C. Dissolve residue in proper volume of methanol for LC analysis (1.0 mL, or as appropriate for the expected concentration of analyte).
F. Preparation of Standard Calibration Curve
Check system suitability before determination by injecting standard solution (such as 1.00 mg/mL), then 10 mL of 0.20, 0.40, 1.00, 2.00, and 3.00 mg/mL clopidol working standard solution, D(c), in duplicate under LC conditions. Prepare 5-point standard curve (peak height response, in millimeters, vs clopidol concentration, mg/mL), which should be linear between 0.20 and 3.00 mg/mL. The linear correlation should be $0.99.
G. LC Determination
Inject in duplicate 10 mL test portion extracts into LC system. Peak heights should agree within 5% for duplicate injections. Calculate residue of clopidol in original chicken sample using the following formula: 
Results and Discussion
Of the 19 laboratories that agreed to participate in the study, 18 reported analytical findings. One laboratory was unable to provide results within the deadline because of other commitments. Two laboratories (Nos. 10 and 16) used LC columns and ion exchange resin supplied by the Study Director. All other participants provided their own materials.
Evaluation and Statistical Analysis of Data
The 18 participating laboratories analyzed a total of 252 fortified samples, with 9 laboratories also analyzing 54 clopidol-incurred samples. In total, 306 samples, including 36 blank muscle samples, were included. The analytical results are compiled in Tables 1 and 2 . Data from collaborators 12 and 14 were not included in the statistical analysis. Collaborator 12 reported the use of 50-200 mesh alumina. The method specifies that 100-200 mesh alumina should be used. The size Collaborator 12 used is too fine, which created difficulties in cleanup and recovery of clopidol, while increasing the consumption of methanol and eluting solvent. Based on the deviation from the protocol, the results from this collaborator were not included. Collaborator 14 reported replacement of the 0.5% glacial acetic acid-methanol specified in the method as elution solution for the anion exchange cartridge with 1% glacial acetic acid-methanol. In the preliminary testing of the method, the effects on elution of clopidol using different concentrations of acetic acids was evaluated, and it was demonstrated that using either 0.5 or 1% acetic acid is equally effective (6) . However, when the final extracts are being evaporated, the lower acetic acid content is easier to dry than the increased acetic acid content; therefore, the deviation was considered unacceptable, although it did not appear to affect the results obtained by this collaborator.
The data submitted by the remaining 16 laboratories were subjected to Dixon's Test (11) . A total of 6 outlier results were identified in the fortified samples, 4 of which were reported by Laboratory 16. Laboratory 16 also did not report a result for sample No. 6. The other results from this laboratory were included in the evaluation. Upon elimination of the outliers, the remaining data were evaluated in accordance with the formula of Youden and Steiner (12) regarding the reproducibility standard deviation (s R ), reproducibility relative standard deviation (RSD R ), reproducibility value (R), repeatability standard deviation (s r ), repeatability relative standard deviation (RSD r ), and repeatability values (r). HORRAT values also were calculated (12) . These results are summarized in Tables 2003.04A and 2003.04B.
The results of the statistical analysis show that when the fortification concentration range of the clopidol in chicken muscle was 0.10-5.00 mg/kg, the average recovery range was 81.8-85.4%, RSD R was 11.9-22.6%, and RSD r was 9.9-15.1%. For clopidol-incurred samples in the concentration range from 0.10 to 0.687 mg/kg, the mean determinations were 0.099-0.659 mg/kg. RSD R was 12.6-19.8%, and RSD r was 3. strated that both the between-and within-laboratory precisions were satisfactory irrespective of whether test materials were fortified or incurred. HORRAT values were 0.78-1.1, which indicated that the method performance was acceptable. These also indicated that the use of the spiking solutions was a suitable surrogate for the use of incurred materials in this study.
Specificity of Method
All chromatograms supplied by collaborators were reviewed and no peaks were present which interfered with the determination of clopidol, either at, or in proximity to, the retention time of the clopidol peak. This evaluation indicates that typical chicken muscle samples and the reagents used in the analysis do not produce chromatographic peaks which interfere with the determination of clopidol residues in chicken muscle.
Of the 14 fortified samples analyzed by each laboratory, Nos. 1 and 12 were blank matrix. In the results of the 18 laboratories that reported results, including the 2 excluded for deviations from the protocol, 13 laboratories reported that clopidol residues were not detected (ND) or were below the LOD of 0.005 mg/kg for sample No. 12. The remaining 5 laboratories (Nos. 2, 5, 14, 16, and 17), however, reported positive result ranging from 0.01 to 0.03 mg/kg on sample No. 12. These results all are below the recommended minimum concentration for the method to be used. All laboratories reported that no residues were detected in sample No. 1. As the laboratories obtained their blank muscle material locally, this was attributed to possible cross-interference between samples, rather than to matrix effects. Cross-interference between the samples can be avoided as long as the stipulations of the protocol of the collaborative study are strictly followed. However, laboratories may wish to repeat the analysis of samples at concentrations near the detection limit to ensure that such results are not due to carryover from a previous high positive sample.
Collaborators' Comments
None of the collaborators suggested any revisions to the method. The comments that the majority provided explained how they resolved certain problems encountered in implementation of the method. Some suggestions have been incorporated in the proposed method. Collaborators 1 and 10 mentioned that a 50 mL glass centrifuge tube is too small for preparation of samples. In the method protocol, the recommended volume for the centrifuge tube is changed from 50 to 80 mL. Collaborator 13 said that on the second tissue extraction the sediment plug was broken up with a spatula, as mixing on a Vortex mixer alone was unable to break the pellet up. This has been included in the proposed method. Collaborator 18 pointed out that there was floating matter in the final extract solutions. We believe this might possibly be traced to the extremely fine mesh of the alumina used or inappropriate glass wool filled at the bottom of the alumina column. Nevertheless, it did not affect the analytical results. Collaborator 10 commented that the operation of the method was slow and time-consuming, and consumed large volumes of solvents.
Recommendations
The statistical analysis of the analytical data of these 306 collaborative study samples demonstrated that the accuracy and precision of the proposed method are in conformity with the requirements specified by AOAC INTERNA-TIONAL. It is therefore recommended that the method "Determination of clopidol residues in chicken tissues by liquid chromatography" be adopted Official First Action.
